CME/CE

Episodes 129-134 of 134

• 

  MinuteCE®

  Hypertrophic cardiomyopathy & heart failure: exploring new options

  1.00 credit 3 episodes

  • 

    

    Rudolf de Boer, MD, PhD

  • 

    

    Mariana Brandão, MD

  • 

    

    Iacopo Olivotto, MD

  1.00 credit 3 episodes

• 

  RestartResume

  A call to action: optimizing treatment in CKD

  RestartResume

  A call to action: optimizing treatment in CKD

  MinuteCE®

  A call to action: optimizing treatment in CKD

  1.00 program credit

  • 

    

    Meg Jardine, MD, PhD

  1.00 program credit

• 

  RestartResume

  What is the evidence of SGLT2i in CKD?

  RestartResume

  What is the evidence of SGLT2i in CKD?

  MinuteCE®

  What is the evidence of SGLT2i in CKD?

  1.00 program credit

  • 

    

    Hiddo L. Heerspink, PhD

  1.00 program credit

• 

  RestartResume

  When and how to initiate SGLT2i in CKD

  RestartResume

  When and how to initiate SGLT2i in CKD

  MinuteCE®

  When and how to initiate SGLT2i in CKD

  1.00 program credit

  • 

    

    David Wheeler, MB, CHB, MD, FRCP

  1.00 program credit

• 

  RestartResume

  Primary care role in CKD

  RestartResume

  Primary care role in CKD

  MinuteCE®

  Primary care role in CKD

  1.00 program credit

  • 

    

    Richard Hobbs, MD

  1.00 program credit

• 

  MinuteCE®

  4 things to know about CKD and SGLT2i

  1.00 credit 4 episodes

  • 

    

    Hiddo L. Heerspink, PhD

  • 

    

    David Wheeler, MB, CHB, MD, FRCP

  • 

    

    Meg Jardine, MD, PhD

  • 

    

    Richard Hobbs, MD

  1.00 credit 4 episodes